The American Diabetes Association's annual conference recently took place in New Orleans, drawing attention to several key topics in diabetes research and treatment.
Among the highlights were discussions surrounding newer GLP-1 medications, which are gaining traction in the management of diabetes.
Additionally, there was pushback regarding proposed cuts to research funding, reflecting concerns within the community about the future of diabetes research.
The event also featured a protest, signaling ongoing advocacy efforts related to diabetes care and funding.